Intravascular large B-cell lymphoma: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 42: | Line 42: | ||
==Case Studies== | ==Case Studies== | ||
[[Intravascular large B-cell lymphoma case study one|Case #1]] | [[Intravascular large B-cell lymphoma case study one|Case #1]] | ||
==Related Chapters== | ==Related Chapters== | ||
Line 51: | Line 49: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{Hematological malignancy histology}} | {{Hematological malignancy histology}} |
Revision as of 16:57, 12 September 2012
Intravascular large B-cell lymphoma | ||
ICD-10 | C85.1 | |
---|---|---|
ICD-O: | 9680/0, 9699/3, 9699/3 | |
MeSH | C04.557.386.480.150 |
Intravascular large B-cell lymphoma Microchapters |
Differentiating Intravascular large B-cell lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Intravascular large B-cell lymphoma On the Web |
American Roentgen Ray Society Images of Intravascular large B-cell lymphoma |
Directions to Hospitals Treating Intravascular large B-cell lymphoma |
Risk calculators and risk factors for Intravascular large B-cell lymphoma |
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Intravascular large B-cell lymphoma from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | CT | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies